Aarti Pharmalabs Limited (AARTIPHARM.BO)
INR 642.25
(-1.17%)
INR 642.25
(-1.17%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.61 Billion INR | 37.79% |
| 2022 | 1.89 Billion INR | -44.4% |
| 2021 | 3.4 Billion INR | 147473.61% |
| 2020 | -2.31 Million INR | 0.0% |
| 2019 | -2.31 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 3.32 Billion INR | 266.49% |
| 2024 Q1 | 943.16 Million INR | -63.89% |
| 2023 Q1 | 631.8 Million INR | -66.67% |
| 2023 FY | 2.61 Billion INR | 37.79% |
| 2023 Q2 | 1.92 Billion INR | 204.91% |
| 2023 Q3 | 697.7 Million INR | -63.78% |
| 2023 Q4 | 2.61 Billion INR | 274.36% |
| 2022 FY | 1.89 Billion INR | -44.4% |
| 2022 Q4 | 1.89 Billion INR | -13.09% |
| 2022 Q3 | 2.18 Billion INR | 0.0% |
| 2021 Q1 | -2.24 Million INR | 0.0% |
| 2021 FY | 3.4 Billion INR | 147473.61% |
| 2021 Q4 | 2.56 Billion INR | -0.0% |
| 2021 Q3 | 2.56 Billion INR | 114670.93% |
| 2021 Q2 | -2.24 Million INR | 0.0% |
| 2020 FY | -2.31 Million INR | 0.0% |
| 2019 FY | -2.31 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 3.86 Billion INR | 32.437% |
| Aurobindo Pharma Limited | 3.69 Billion INR | 29.28% |
| Glenmark Life Sciences Limited | -2.84 Billion INR | 191.882% |
| Granules India Limited | 9.28 Billion INR | 71.875% |
| Indoco Remedies Limited | 6.47 Billion INR | 59.67% |
| Achyut Healthcare Limited | -3.74 Million INR | 69825.04% |
| Ajanta Pharma Limited | -954.9 Million INR | 373.526% |
| Alkem Laboratories Limited | -1.6 Billion INR | 262.29% |
| Alpa Laboratories Limited | 35.36 Million INR | -7285.968% |
| Brooks Laboratories Limited | 49.48 Million INR | -5178.165% |
| AstraZeneca Pharma India Limited | -5.01 Billion INR | 152.108% |
| Bajaj HealthCare Limited | 3.29 Billion INR | 20.826% |
| Bliss GVS Pharma Limited | -1.15 Billion INR | 325.601% |
| Dr. Reddy's Laboratories Limited | 12.91 Billion INR | 79.773% |
| Eris Lifesciences Limited | 13.8 Billion INR | 81.082% |
| FDC Limited | -57.75 Million INR | 4622.614% |
| Glenmark Pharmaceuticals Limited | -4.28 Billion INR | 160.951% |
| Gufic Biosciences Limited | 3.19 Billion INR | 18.233% |
| Ind-Swift Laboratories Limited | -4.15 Billion INR | 162.891% |
| Ipca Laboratories Limited | 11.41 Billion INR | 77.119% |
| Jagsonpal Pharmaceuticals Limited | -1.38 Billion INR | 287.916% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -35.127% |
| Lasa Supergenerics Limited | 205.79 Million INR | -1169.151% |
| Laurus Labs Limited | 24.38 Billion INR | 89.289% |
| Lupin Limited | 17.19 Billion INR | 84.808% |
| Mankind Pharma Limited | -9.9 Billion INR | 126.362% |
| Medicamen Biotech Limited | 160.31 Million INR | -1529.22% |
| Medico Remedies Limited | 78.67 Million INR | -3219.776% |
| Megasoft Limited | 1.28 Billion INR | -103.173% |
| NATCO Pharma Limited | -5.81 Billion INR | 144.901% |
| Piramal Pharma Limited | 42.27 Billion INR | 93.822% |
| RPG Life Sciences Limited | -364.7 Million INR | 816.178% |
| Sigachi Industries Limited | 859.94 Million INR | -203.727% |
| Sun Pharmaceutical Industries Limited | -72.47 Billion INR | 103.604% |
| Suven Pharmaceuticals Limited | 144.97 Million INR | -1701.609% |
| Syncom Formulations (India) Limited | 46.21 Million INR | -5552.117% |
| Unichem Laboratories Limited | 931.91 Million INR | -180.272% |
| Wanbury Limited | 1.1 Billion INR | -136.184% |
| Windlas Biotech Limited | -273.04 Million INR | 1056.6% |
| ZIM Laboratories Limited | 983.6 Million INR | -165.544% |
| Zydus Lifesciences Limited | 3.91 Billion INR | 33.234% |
| Sun Pharma Advanced Research Company Limited | -941.8 Million INR | 377.331% |
| Divi's Laboratories Limited | -39.77 Billion INR | 106.568% |
| Hester Biosciences Limited | 2.29 Billion INR | -14.02% |
| Procter & Gamble Health Limited | -2.34 Billion INR | 211.239% |
| Amrutanjan Health Care Limited | -248.79 Million INR | 1149.833% |
| Bal Pharma Limited | 1.26 Billion INR | -106.709% |
| Strides Pharma Science Limited | 23.25 Billion INR | 88.769% |
| Venus Remedies Limited | -267.7 Million INR | 1075.682% |
| Nectar Lifesciences Limited | 6.15 Billion INR | 57.58% |
| Shilpa Medicare Limited | 9.06 Billion INR | 71.201% |
| Aarti Drugs Limited | 5.54 Billion INR | 52.925% |
| IOL Chemicals and Pharmaceuticals Limited | -1.1 Billion INR | 337.165% |
| Suven Life Sciences Limited | -1.63 Billion INR | 259.974% |
| Ind-Swift Limited | 9.5 Billion INR | 72.531% |
| Valiant Laboratories Limited | -295.03 Million INR | 985.294% |
| J. B. Chemicals & Pharmaceuticals Limited | 2.82 Billion INR | 7.419% |
| Solara Active Pharma Sciences Limited | 10.02 Billion INR | 73.957% |
| Themis Medicare Limited | 764.96 Million INR | -241.442% |
| Hikal Limited | 7.96 Billion INR | 67.216% |
| Torrent Pharmaceuticals Limited | 31.83 Billion INR | 91.794% |
| Sequent Scientific Limited | 4.17 Billion INR | 37.494% |
| Novartis India Limited | -5.89 Billion INR | 144.336% |
| Wockhardt Limited | 18.27 Billion INR | 85.704% |
| Jubilant Pharmova Limited | 27.07 Billion INR | 90.352% |
| Biofil Chemicals and Pharmaceuticals Limited | -18.44 Million INR | 14259.709% |
| Neuland Laboratories Limited | -214.05 Million INR | 1320.183% |
| Morepen Laboratories Limited | -231.17 Million INR | 1229.842% |
| Kilitch Drugs (India) Limited | 120.03 Million INR | -2075.876% |
| Mangalam Drugs & Organics Limited | 975.81 Million INR | -167.665% |